Shopping Cart
Remove All
Your shopping cart is currently empty
Zenarestat is an orally active aldose reductase inhibitor capable of ameliorating diabetic peripheral neuropathy in rats with type 2 diabetes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $149 | - | In Stock |
| Description | Zenarestat is an orally active aldose reductase inhibitor capable of ameliorating diabetic peripheral neuropathy in rats with type 2 diabetes. |
| In vivo | Methods: Zenarestat (3.2 mg/kg and 32 mg/kg, once daily for 8 consecutive weeks) was orally administered to Zucker diabetic fatty (ZDF) rats to investigate the effects of zenarestat on peripheral neuropathy in the type 2 diabetes animal model ZDF rats.
Results: At the dose of 3.2 mg/kg, zenarestat did not show significant effects on FML latency delay and MNCV slowing; however, at the dose of 32 mg/kg, zenarestat treatment significantly improved these neurologic disorders in ZDF rats and reduced the accumulation of sorbitol in nerves to levels nearly equivalent to those in lean rats.[3] |
| Synonyms | FR-74366, FR74366, FR 74366, CI-1014, CI1014 |
| Molecular Weight | 441.64 |
| Formula | C17H11BrClFN2O4 |
| Cas No. | 112733-06-9 |
| Smiles | O=C(O)CN1C(=O)N(C(=O)C2=CC=C(Cl)C=C21)CC3=CC=C(Br)C=C3F |
| Relative Density. | 1.31g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (181.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.